Related Experiment Videos
Mechanisms by which human gliomas may escape cellular immune attack
Acta Neurochirurgica
|January 1, 1982
Summary
Human gliomas can evade immune attack through multiple mechanisms. This study identifies three key ways these brain tumors escape cellular immune responses, impacting immunotherapy strategies.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Research
Background:
- Glioma patients mount humoral immune responses to tumors.
- Evidence for significant cellular immune responses in glioma patients is limited and debated.
Purpose of the Study:
- Investigate human glioma properties enabling immune system evasion.
- Examine the capacity of cultured human glioma cells to stimulate allogeneic cytolytic lymphocyte responses in vitro.
Main Methods:
- Utilized mixed lymphocyte-tumor cultures with cultured human glioma cell lines.
- Assessed the ability of glioma cells to elicit allogeneic cytolytic lymphocyte responses.
- Analyzed mechanisms of immune escape in non-stimulating glioma lines.
Main Results:
- Five out of ten glioma lines failed to stimulate cytolytic lymphocyte responses.
- This occurred despite the presence of detectable surface alloantigens.
- Identified three escape mechanisms: impaired immunogenicity, protective mucopolysaccharide coat, and immunosuppressive substances.
Conclusions:
- Human gliomas employ diverse strategies to evade cellular immune attack.
- Understanding these mechanisms is crucial for developing effective glioma immunotherapies.